Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis

被引:38
|
作者
Chasset, Francois [1 ]
Frances, Camille [1 ]
机构
[1] Univ Pierre & Marie Curie Paris VI, Hop Tenon, AP HP, Serv Dermatol Allergol, 4 Rue Chine, F-75020 Paris, France
关键词
Takayasu arteritis; Giant-cell arteritis; Polyarteritis nodosa; Kawasaki disease; GIANT-CELL ARTERITIS; SYSTEMIC-NECROTIZING-VASCULITIDES; PLACEBO-CONTROLLED TRIAL; OF-THE-LITERATURE; POLYARTERITIS-NODOSA; TAKAYASU ARTERITIS; KAWASAKI-DISEASE; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; SCALP NECROSIS;
D O I
10.1007/s12016-017-8612-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although such vessels are not found in the skin. Cutaneous manifestations may be related to a direct skin localization of the systemic vasculitis or a non-specific process associated with the vasculitis. According to the 2012 International Chapel Hill consensus, the two major variants of large-vessel vasculitides are Takayasu arteritis and giant-cell arteritis. In Europe and North America, acute inflammatory nodules or erythema nodosum-like lesions are the most commonly observed skin lesions with Takayasu arteritis. Medium-sized arteriole vasculitis of the dermis or subcutis but also septal or lobular panniculitis may be found during pathological examination. In Japan, widespread pyoderma gangrenosum-like lesions are more frequent. Cutaneous manifestations of giant-cell arteritis are rare; they are ischemic, linked to arterial occlusions, or non-ischemic, with various mechanisms. The two major medium-vessel vasculitides are Kawasaki disease and polyarteritis nodosa. Kawasaki disease is characterized by a mucocutaneous lymph node syndrome without skin vasculitis. Two subsets of polyarteritis nodosa with different skin manifestations are described, without transition from one to the other. In the systemic subset, the most frequent skin lesions are in the order of frequency purpura, livedo, and nodules. Cutaneous polyarteritis nodosa mainly features nodules, livedo racemosa, and ulcerations. Genetic screening and measurement of plasma levels of adenosine deaminase 2 should be considered for patients with uncommon systemic polyarteritis nodosa or early-onset cutaneous polyarteritis nodosa.
引用
收藏
页码:452 / 468
页数:17
相关论文
共 50 条
  • [31] Efficacy of baricitinib for refractory large-vessel vasculitis
    Regent, Alexis
    Terrier, Benjamin
    Legendre, Paul
    Wartski, Myriam
    Cohen, Pascal
    Mouthon, Luc
    Le Jeunne, Claire
    RHEUMATOLOGY, 2021, 60 (11) : E389 - E391
  • [32] Angiographic Progression of Disease in Large-Vessel Vasculitis
    Quinn, Kaitlin
    Dashora, Himanshu
    Ahlman, Mark
    Novakovich, Elaine
    Grayson, Peter C.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [33] Current and emerging therapies in large-vessel vasculitis
    Kermani, Tanaz A.
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2018, 57 (09) : 1513 - 1524
  • [34] New Therapeutic Approaches to Large-Vessel Vasculitis
    Kaymakci, Mahmut S.
    Warrington, Kenneth J.
    Kermani, Tanaz A.
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 427 - 442
  • [35] New treatment strategies in large-vessel vasculitis
    Unizony, Sebastian
    Stone, John H.
    Stone, James R.
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (01) : 3 - 9
  • [36] The potentials and importance of imaging in large-vessel vasculitis
    Kolossvary Endre
    Balazs Gyorgy
    Dosa Edit
    Morayszki Monika
    Jarai Zoltan
    Farkas Katalin
    ORVOSI HETILAP, 2020, 161 (23) : 939 - 950
  • [37] Medium and large vessel vasculitis
    Clivati Brandt, Hebert Roberto
    Arnone, Marcelo
    Sakai Valente, Neusa Yuriko
    Sotto, Mirian Nacagami
    Criado, Paulo Ricardo
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2009, 84 (01) : 55 - 67
  • [38] PET/CT for Diagnosis and Management of Large-Vessel Vasculitis
    Pelletier-Galarneau, Matthieu
    Ruddy, Terrence D.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (05)
  • [39] What is the best approach to diagnosing large-vessel vasculitis?
    Schmidt, WA
    Gromnica-Ihle, E
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (02): : 223 - 242
  • [40] Tocilizumab: a novel therapy for patients with large-vessel vasculitis
    Salvarani, Carlo
    Magnani, Luca
    Catanoso, Mariagrazia
    Pipitone, Nicolo
    Versari, Annibale
    Dardani, Lucia
    Pulsatelli, Lia
    Meliconi, Riccardo
    Boiardi, Luigi
    RHEUMATOLOGY, 2012, 51 (01) : 151 - 156